₹427.95
▲ +9.25 +2.21%
17 Jul 2026
BSE Listed
Titan Biotech Ltd. (524717)
Volume: 5,039Avg Vol 1W: 24,885Avg Vol 1M: 28,01152W Range:₹82.31₹555.65
Key Ratios
Checked 10h agoMarket Cap₹1,704 Cr
Current Price₹427.95
Previous Close₹418.7
High / Low (52w)₹555.65 / ₹82.31
Volume5,039
Avg Vol (1W)24,885
Avg Vol (1M)28,011
Stock P/E57.04
Book Value₹43.94
Dividend Yield12%
ROE16.46%
ROA12.83%
Revenue (TTM)—
Revenue Growth—
Profit Margin14.49%
Total Debt—
Shares Outstanding4 Cr
Face Value—
EPS (TTM)₹7.23
P/B9.39
Debt / Equity0.04
50 DMA₹428.61
200 DMA₹311.02
Day change+2.21%
Price Chart
₹427.95▲ 372.40% · 1Y
2025-07-172026-07-17
20-day avg volume: 29K shares
Pros
- Healthy return on equity of 16.5%.
- Pays a dividend yield of 12.0%.
- Company is almost debt-free.
Cons
- Stock trades at a high P/E of 57.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹43 Cr | ₹40 Cr | ₹38 Cr | ₹35 Cr | ₹47 Cr | ₹54 Cr | ₹57 Cr | ₹49 Cr |
| EBITDA | ₹8 Cr | ₹7 Cr | ₹5 Cr | ₹5 Cr | ₹8 Cr | ₹9 Cr | ₹11 Cr | ₹11 Cr |
| Net Profit | ₹6 Cr | ₹7 Cr | ₹4 Cr | ₹4 Cr | ₹7 Cr | ₹8 Cr | ₹9 Cr | ₹7 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹58 Cr | ₹66 Cr | ₹80 Cr | ₹143 Cr | ₹124 Cr | ₹146 Cr | ₹166 Cr | ₹160 Cr |
| EBITDA | ₹6 Cr | ₹8 Cr | ₹12 Cr | ₹45 Cr | ₹30 Cr | ₹29 Cr | ₹33 Cr | ₹25 Cr |
| Net Profit | ₹3 Cr | ₹4 Cr | ₹7 Cr | ₹30 Cr | ₹22 Cr | ₹25 Cr | ₹25 Cr | ₹22 Cr |
| EPS | 3.29 | 4.26 | 8.55 | 36.71 | 26.24 | 30.06 | 30.07 | 26.06 |
Balance Sheet
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹57 Cr | ₹65 Cr | ₹76 Cr | ₹101 Cr | ₹108 Cr | ₹135 Cr | ₹157 Cr | ₹175 Cr |
| Total Liabilities | ₹31 Cr | ₹31 Cr | ₹34 Cr | ₹28 Cr | ₹22 Cr | ₹25 Cr | ₹24 Cr | ₹21 Cr |
| Equity | ₹26 Cr | ₹34 Cr | ₹42 Cr | ₹72 Cr | ₹86 Cr | ₹110 Cr | ₹133 Cr | ₹153 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹3 Cr | ₹7 Cr | ₹8 Cr | ₹30 Cr | ₹29 Cr | ₹29 Cr | ₹29 Cr | ₹26 Cr |
| Investing | ₹-6 Cr | ₹-4 Cr | ₹-2 Cr | ₹-5 Cr | ₹-16 Cr | ₹-21 Cr | ₹-20 Cr | ₹-10 Cr |
| Financing | ₹0 Cr | ₹0 Cr | ₹-4 Cr | ₹-11 Cr | ₹-4 Cr | ₹-2 Cr | ₹-3 Cr | ₹-8 Cr |
| Free Cash Flow | ₹3 Cr | ₹7 Cr | ₹8 Cr | ₹30 Cr | ₹29 Cr | ₹29 Cr | ₹29 Cr | ₹26 Cr |
Shareholding
Promoter 55.78% Institutions 0.01% Public 44.21%
Efficiency & Working Capital
ROCE20.9%
Interest Coverage31.5
Dividend Payout—
Debtor Days44 d
Inventory Days118 d
Payable Days12 d
Cash Conversion Cycle150 d
Working Capital Days162 d
Shareholding Details
As of 2026-06-30
Promoter55.8%
FII0%
DII0%
Institutions0%
Public44.2%
Promoter Pledge0%
No. of Shareholders18,671
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 55.9% | 55.9% | 55.9% | 55.9% | 55.9% | 55.9% | 55.9% | 55.9% | 55.8% | 55.8% | 55.8% | 55.8% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0.2% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 44.1% | 44.1% | 43.9% | 44.1% | 44.1% | 44.1% | 44.1% | 44.1% | 44.2% | 44.2% | 44.2% | 44.2% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 17,455 | 15,756 | 15,876 | 15,850 | 15,700 | 16,038 | 16,370 | 16,328 | 16,040 | 16,367 | 17,457 | 18,671 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Titan Securities Ltd | Shareholding of Promoter and Promoter Group | 33.6% | 1.39 Cr |
| Tanita Leasing & Finance Limited | Shareholding of Promoter and Promoter Group | 9.5% | 39,22,275 |
| Connoisseur Management Services Private Limit | Shareholding of Promoter and Promoter Group | 6.8% | 28,00,000 |
| Manish Goel | Public Shareholding | 2.8% | 11,58,649 |
| Titan Biotech Limited Unclaimed Suspense Dema | Public Shareholding | 2.4% | 9,76,005 |
| Suresh Chand Singla | Shareholding of Promoter and Promoter Group | 1.3% | 5,28,355 |
| Manju Singla | Shareholding of Promoter and Promoter Group | 0.9% | 3,56,050 |
| Madhu Gupta | Shareholding of Promoter and Promoter Group | 0.8% | 3,32,550 |
| Raja Singla | Shareholding of Promoter and Promoter Group | 0.7% | 3,05,500 |
| Supriya Singla | Shareholding of Promoter and Promoter Group | 0.7% | 2,72,465 |
| Udit Singla | Shareholding of Promoter and Promoter Group | 0.6% | 2,50,000 |
| Shivom Singla | Shareholding of Promoter and Promoter Group | 0.4% | 1,77,000 |
| Naresh Kumar Singla | Shareholding of Promoter and Promoter Group | 0.4% | 1,72,550 |
| Naresh Kumar Singla Huf | Shareholding of Promoter and Promoter Group | 0.1% | 50,000 |
| Ravinder Gupta Huf | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Ravinder Gupta | Shareholding of Promoter and Promoter Group | 0% | 0 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Madhu Gupta | 0 | 0% | 2026-06-30 |
| Manju Singla | 0 | 0% | 2026-06-30 |
| Naresh Kumar Singla | 0 | 0% | 2026-06-30 |
| Raja Singla | 0 | 0% | 2026-06-30 |
| Ravinder Gupta | 0 | 0% | 2026-06-30 |
| Shivom Singla | 0 | 0% | 2026-06-30 |
| Supriya Singla | 0 | 0% | 2026-06-30 |
| Suresh Chand Singla | 0 | 0% | 2026-06-30 |
| Udit Singla | 0 | 0% | 2026-06-30 |
| Naresh Kumar Singla Huf | 0 | 0% | 2026-06-30 |
| Ravinder Gupta Huf | 0 | 0% | 2026-06-30 |
| Connoisseur Management Services Private Limit | 0 | 0% | 2026-06-30 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Rohit Jain | Chairman & Independent Directo | 2025 |
| Naresh Kumar Singla | ED / MD / Promoter | 2025 |
| Suresh Chand Singla | ED / MD / Promoter | 2025 |
| Manju Singla | Non-Exec & Non-Independent Dir | 2025 |
| Supriya Singla | Non-Exec & Non-Independent Dir | 2025 |
| Dhairya Madan | Independent Non Exe. Director | 2025 |
| Brijesh Kumar Singh | Independent Non Exe. Director | 2025 |
| Abhishek Agarwal | Independent Non Exe. Director | 2025 |
| Raja Singla | WTD & Executive Director | 2025 |
| Udit Singla | E D & Wholetime Director | 2025 |
| Shivom Singla | E D & Wholetime Director | 2025 |
| Debendra Kumar Sabat | Independent Non Exe. Director | 2025 |
| CHARANJIT SINGH | Company Sec. & Compli. Officer | 2025 |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| Domestic | ₹103 Cr | 65.5% |
| Overseas | ₹54 Cr | 34.5% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 10 | 8 | 8 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| split | 2026-02-20 | 1:5 | face value change from 10 to 2 |
| dividend | 2025-09-19 | ₹2 (20%) | Final |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 10 | 0 | 5 | 26 | 41 |
| 2025 | 0 | 3 | 0 | 0 | 1 | 4 |
| 2025 | 0 | 0 | 0 | 0 | 1 | 1 |
Company Information
🌐 www.titanbiotechltd.com ↗
📍 A-902 A RIICO Industrial Area, Phase III Alwar District, Bhiwadi, Rajasthan, 301019
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search